Phase 2 Placebo-controlled, Randomized Study of Oral Immunomodulator in TB and TB/HIV Patients.
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2015
At a glance
- Drugs Hepcortespenlisimut-L (Primary) ; Ethambutol; Isoniazid; Pyrazinamide; Rifampicin
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 06 Jun 2015 Last checked against ClinicalTrials.gov record.
- 14 Jul 2011 Final results were presented at the Third Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease.
- 21 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.